Triveni Bio has dosed the first healthy volunteers in its Phase I study of TRIV-573, a half-life extended bispecific antibody...
Regeneron Pharmaceuticals has signed a $2.32bn deal with Parabilis Medicines to develop therapeutic candidates, with a focus on AHCs.The post...
PainTEQ has announced the commercial launch of TRAQ, an implant developed for posterior SI joint fusion, in the US.The post...
Regeneron Pharmaceuticals has reported that its Phase III trial assessing fianlimab and cemiplimab for metastatic melanoma failed to reach statistical...
The FDA has approved Daiichi Sankyo and AstraZeneca’s Enhertu for two new indications in HER2-positive early breast cancer.The post FDA...
Ardent Health and Fujifilm Healthcare are to bring Synapse enterprise imaging solutions to its acute care hospitals across six US...
Massive Bio has signed a strategic partnership with Just Worldwide to connect more cancer patients to clinical studies.The post Massive...
Kyowa Kirin has received approval from the FDA for a dosing update to the Crysvita prescribing information, introducing a new...
Dr Michael Suk, CEO of physician advocacy platform MDEnvoy, reflects on the link between physician burnout and turnover, and what...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.